Acute Promyelocytic Leukemia |
* Department of Haematology, Christian Medical College, Vellore, India
° Cytogenetics Unit, Christian Medical College, Vellore, India
Correspondence: Vikram Mathews, Department of Haematology, Christian Medical College, Vellore, 632004 India. Phone: international +91.416.2282891. Fax: international +91.416.2232035. E-mail: vikram{at}cmcvellore.ac.in
Ninety-eight newly diagnosed cases of PML-RAR
positive APL were treated with a regimen of single agent ATO. FLT3 activating mutations were seen in 33% and an additional cytogenetic finding was noted in 23.2%. FLT3 activating mutations were significantly associated with a bcr3 PML-RAR
isoform (p=0.012) and a delay in achieving a molecular remission (p=0.022). Neither FLT3 activating mutations nor secondary cytogenetic changes had an impact on clinical outcome.
Key words: acute promyelocytic leukemia, arsenic trioxide, FLT3 mutation, cytogenetics.
This article has been cited by other articles:
![]() |
M. S. Tallman and J. K. Altman How I treat acute promyelocytic leukemia Blood, December 10, 2009; 114(25): 5126 - 5135. [Abstract] [Full Text] [PDF] |
||||